Pretransplant ESA Hyporesponsiveness May Worsen Post-Transplant Outcomes Renal and Urology News PHILADELPHIA—Two research teams have found that hyporesponsiveness to erythropoiesis stimulating agents (ESAs) prior to renal transplantation is associated with a higher risk of post-transplant allograft failure and mortality, according to study ... |
